Réactivité et pérennité des soins psychiatriques en France à l’épreuve du COVID-19

R. Bocher(Centre Hospitalier Universitaire de Nantes), Vincent Laprévote(Centre Hospitalier Régional et Universitaire de Nancy), Pierre Gayet(Centre Hospitalier Universitaire de Nantes), Philip Gorwood(Inserm), C.J. Jansen(Centre Hospitalier Régional et Universitaire de Nancy)
L Encéphale
May 26, 2020
10.1016/j.encep.2020.05.004
Cited by 31

Related Papers

How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
|World Psychiatry|2023|751
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
|American Journal of Psychiatry|2021|707